RERAX
Price
$56.76
Change
+$0.02 (+0.04%)
Updated
Jun 5 closing price
Net Assets
133.44B
RIVHX
Price
$19.19
Change
-$0.07 (-0.36%)
Updated
Jun 5 closing price
Net Assets
2.4B
Interact to see
Advertisement

RERAX vs RIVHX

Header iconRERAX vs RIVHX Comparison
Open Charts RERAX vs RIVHXBanner chart's image
American Funds EUPAC R1
Price$56.76
Change+$0.02 (+0.04%)
VolumeN/A
Net Assets133.44B
American Funds International Vntg R-2E
Price$19.19
Change-$0.07 (-0.36%)
VolumeN/A
Net Assets2.4B
RERAX vs RIVHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RERAX vs. RIVHX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERAX is a Buy and RIVHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 133B vs. RIVHX (2.4B). RIVHX pays higher dividends than RERAX: RIVHX (0.76) vs RERAX (0.42). RERAX was incepted earlier than RIVHX: RERAX (23 years) vs RIVHX (6 years). RERAX (1.57) is less costly to investors than RIVHX (1.33). RERAX is a more actively managed with annual turnover of: 30.00 vs. RIVHX (20.00). RERAX (250) and RIVHX (250) have matching initial minimum investment requirements. RIVHX annual gain was more profitable for investors over the last year : 11.06 vs. RERAX (1.91). RIVHX return over 5 years is better than : 40.79 vs. RERAX (13.80).
RERAXRIVHXRERAX / RIVHX
Total Expense Ratio1.571.33118%
Annual Report Gross Expense Ratio1.571.33118%
Fund Existence23 years6 years-
Gain YTD12.51218.30568%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets133B2.4B5,553%
Annual Yield % from dividends0.420.7656%
Returns for 1 year1.9111.0617%
Returns for 3 years14.6036.3440%
Returns for 5 years13.8040.7934%
Returns for 10 years19.61N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZVSA0.650.02
+3.96%
ZyVersa Therapeutics
KRRO12.350.47
+3.96%
Korro Bio
BCYC8.510.05
+0.59%
Bicycle Therapeutics plc
MNDY305.00-0.19
-0.06%
monday.com Ltd
CWK10.18-0.09
-0.88%
Cushman & Wakefield plc